HOME › DRUGS › INSULIN DETEMIR RECOMBINANT
ACTIVE SUBSTANCE / INN

INSULIN DETEMIR RECOMBINANT

Brand name(s): LEVEMIR FLEXTOUCH, LEVEMIR INNOLET, LEVEMIR FLEXPEN, LEVEMIR, LEVEMIR PENFILL
FDA LISTED
PRESCRIPTION
DISCONTINUED
BLA021536
ACTIVE SUBSTANCE
Insulin Detemir Recombinant
REGULATORS
FDA
SPONSORS / MAH
NOVO NORDISK INC
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LEVEMIR FLEXTOUCHBLA021536NOVO NORDISK INCPrescription
LEVEMIR INNOLETBLA021536NOVO NORDISK INCDiscontinued
LEVEMIRBLA021536NOVO NORDISK INCPrescription
LEVEMIR PENFILLBLA021536NOVO NORDISK INCDiscontinued
LEVEMIR FLEXPENBLA021536NOVO NORDISK INCDiscontinued

FULL INTELLIGENCE ON INSULIN DETEMIR RECOMBINANT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →